Overview

A Study of Levornidazole Disodium Phosphate for Injection vs. Ornidazole in Treatment of Postoperative Intra-Abdominal Infections Caused by Anaerobic Bacteria

Status:
COMPLETED

Trial end date:
2024-10-14

Target enrollment:

Participant gender:

Summary

Anaerobic infections are very common in clinical practice. Poor control of anaerobic infections in patients undergoing abdominal surgery may lead to the occurrence of complications. The aim of this study is to explore the efficacy and safety of Levornidazole Phosphate Disodium for Injection in the treatment of patients with postoperative intra-abdominal infections caused by anaerobic bacteria.

Phase:

PHASE4

Details

Lead Sponsor:

Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd

Treatments:

Injections
Ornidazole
Sodium Chloride